Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02ZBW
|
||||
| Former ID |
DIB005411
|
||||
| Drug Name |
LC-150444
|
||||
| Synonyms |
LCD15-0444; Dipeptidyl peptidase IV inhibitors (oral, type 2 diabetes), LG Life Sciences
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 3 | [524679] | ||
| Company |
LG Life Sciences Ltd
|
||||
| Canonical SMILES |
N1(CCCC1C(=O)c1oc(nn1)c1ccccc1)C(=O)CNC(COC)(C)C
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [550262] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||